A team of Noblis and government scientists have reported 10 new genomic signatures of the Ebola virus in a paper published in the Viruses journal, which the nonprofit organization says could indicate potential shortcomings in current diagnostic techniques.
Noblis said Thursday it collaborated with the Defense Department‘s Medical Countermeasure Systems organization and used the organization’s BioVelocity tool to help identify genomic signatures Noblis says current technology could not find.
“The diagnostics now in use have not been tested against sequences from these new variants and may not target the genetic regions that detect all the variants,” said Noblis scientist Walter Berger.
He added that BioVelocity works to facilitate complete, quick and accurate genome identification by analyzing large volumes of DNA sequencing data.